IMS user group event 2017

IMS

This year's annual IMS user group event took place on 18th July 2017, at Liverpool John Moores University. More details and presentations from the event are available on the IMS user group event page.

Public Health Institute

Public Health Institute
The Centre for Public Health was recently granted Institute status and on 1st August 2016 we became the Public Health Institute. More information about the Public Health Institute is available at: www.ljmu.ac.uk/phi

IPEDs Survey 2016 - Results

Public Health Institute
The National IPED Info Survey is an annual survey exploring image and performance drug use in Wales, England and Scotland. The report from the 2016 survey is available here: 2016 Survey Results

North West Coasts Awards 2015 Shortlisted finalist

North West Coast Awards
The Integrated Monitoring System (IMS) was recognised as a shortlisted finalist in the ‘Best example of advancing local NHS systems for innovation’ category at the 2015 North West Coast Research and Innovation Awards. The North West Coast Research and Innovation Awards is a collaborative celebration event between the North West Coast Academic Health Science Network, and CRN: North West Coast: www.nwcawards.co.uk

Featured in RSPH Improve & Protect programme

RSPH
IMS is featured in the Improve and Protect programme produced by RSPH and ITN Productions, the programme features monitoring systems provided by the Public Health Institute. An excerpt from the programme is available on our media & videos page. The full programme and further details about RSPH on their webpages: www.rsph.org.uk

News & resource links

UK Drug strategy 2017

The drug strategy sets out how the government and its partners, at local, national and international levels, will take new action to tackle drug misuse and the harms it causes.

Posted: 14 July 2017

RSPH: Drug policy reform 'Taking a New Line on Drugs'

RSPH are calling for measures aimed at moving UK drugs strategy away from a predominantly criminal justice approach towards one based on public health and harm reduction. Their report 'Taking a New Line on Drugs' proposes a new approach to UK drug policy, featuring opinion from PHI director Jim McVeigh.

Posted: 16 June 2016

Guidance: Widening the availability of Naloxone

Naloxone is the emergency antidote for overdoses caused by heroin and other opiates/opioids (such as methadone and morphine). The main life-threatening effect of heroin and other opiates is to slow down and stop breathing. Naloxone blocks this effect and reverses the breathing difficulties. On the 1 October 2015, new regulations came into force, which allows for widening of the availability of naloxone.

Posted: 10 November 2015

Providing effective services for people who use image and performance enhancing drugs

PHE briefing for local commissioners who are responsible for commissioning services to prevent and treat harms caused by image and performance enhancing drugs (IPEDs) and injecting drug use.

Posted: July 2015

NICE issues quality standards to encourage health living & reduce harm

The National Institute for Health and Care Excellence (NICE) has issued three new quality standards (QS82, QS83 & QS84) to encourage healthy living and reduce harm from smoking, alcohol and physical inactivity.

Posted: March 2015

PHE briefing: Foil provision

PHE briefing regarding legal changes allowing the provision of foil by drug treatment and needle syringe exchange providers.

Posted: August 2014

NICE guidance update: Needle and Syringe Exchange programmes

NICE public health guidance update(PH52) containing recommendations on needle and syringe programmes

Posted: April 2014

NTA Guide: Pharmacy services for drug users

Best practice guidance from the National Treatment Agency (NTA) for commissioners and providers of pharmaceutical services for drug users.

Posted: February 2006